Podcasts about Obesity

The White House has struck a deal with two more drugmakers: Eli Lilly and Novo Nordisk. Centers for Medicare and Medicaid Services administrator Dr. Mehmet Oz discusses the administration's plan to make GLP-1s more affordable for Americans. Tesla shareholders voted to approve Elon Musk's $1 trillion pay package, as long as he reaches their lofty goals for the company. Musk biographer Walter Isaacson discusses the plan of milestones and Musk's history of exceeding investor expectations. Plus, U.S. airlines are beginning to cancel flights to manage shutdown-strained staffing of air traffic controllers, and Warren Buffett issued a warning on AI.  Dr. Mehmet Oz - 21:43Walter Isaacson - 38:56 In this episode:Dr. Mehmet Oz, @DrOzJoe Kernen, @JoeSquawk Andrew Ross Sorkin, @andrewrsorkinKatie Kramer, @Kramer_Katie Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

We start with a federal judge's ruling on coverage for food stamp benefits this month amid a government shutdown. The Supreme Court clears way for President Donald Trump's transgender passport policy. A verdict has been reached in a lawsuit filed by a former Virginia teacher shot by her student. We'll break down the White House's deals that promise to lower prices for some weight loss drugs. Plus, the latest on a case challenging federal agents' crackdown tactics in Chicago. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Cardiologist Dr. Kim Connelly joins us on Diabetes Primetime to explain the powerful connection between inflammation, obesity, and heart disease. He tells us why understanding this link is SO important, and the steps we need to take today for our health.For helpful resources, interviews with diabetes experts, and more, visit our website here: diabeteswhattoknow.com.All content of this channel is owned by What To Know, LLC. and is protected by worldwide copyright laws. You may download content only for your personal use (i.e., for non-commercial purposes) but no modification or further reproduction of the content is permitted. The content may otherwise not be copied or used in any way.Diabetes - What to Know ©️ 2025The medical information in Diabetes - What To Know's content is provided as an information resource only. The content is not in any way intended to be nor should you rely on it as a substitute for professional medical evaluation, diagnosis, advice and treatment.#diabetes #diabetesmanagement #t2d #t2diabetes #type2 #type2diabetes #healthy #diabetescare #weightmanagement

Trump unveils deal to expand coverage and lower costs on obesity drugs Wegovy and Zepbound. AP's Lisa Dwyer reports.

In this episode of The Body Pod, we sit down with Dr. Spencer Nadolsky — The GLP-1 Doc to uncover the truth about GLP-1 medications like Ozempic, Wegovy, and Mounjaro, and what they really mean for women's health, hormones, and sustainable weight loss.We dig into the real science behind appetite, metabolism, and obesity, and why weight gain isn't a failure of willpower but a matter of biology and hormones — especially for women in perimenopause and menopause. Dr. Nadolsky explains the myths around diet culture, Big Pharma, and compounded GLP-1 medications, plus how the medical system often overlooks women struggling with weight, fatigue, and hormonal changes. Whether you're curious about GLP-1 drugs, navigating menopause weight gain, or frustrated by conflicting weight loss advice, this conversation will leave you informed, empowered, and hopeful about your health journey.

Obesity is a serious and costly chronic disease that has been widely recognized as a public health epidemic. Although there are accessible, affordable, and straightforward tools to address it in individuals and broader communities, obesity remains a widespread public health threat that increases one's risk for developing other conditions such as heart disease, type 2 diabetes, and some forms of cancer. Trust for America's Health recently published its “State of Obesity 2025” report, which notes that Arkansas has the fifth-highest adult obesity rate in the nation. To learn more about the state of obesity in Arkansas and policy options to address it, we're joined on this episode of the Wonks at Work podcast by Dr. Arlo Kahn, ACHI's medical director and a professor in the Department of Family and Preventive Medicine at the University of Arkansas for Medical Sciences who has dedicated much of the last quarter century to addressing this issue.

Earnings are filtering in, and companies are seeing a tale of two very different consumers. The group raising concerns about their customer base, and the names not seeing any slowdown. Plus Novo and Eli Lilly nearing a deal with the White house to lower obesity drug prices. What it means for the space, and how it could change medicare coverage of the weight loss drugs.Fast Money Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Did you know your sleep habits could be affecting your weight? Join us with Dr. Michael Mak as he explains the powerful connection between sleep and obesity, why sleep is essential for overall health, and tips for getting a better night's rest.The medical information in this podcast is provided as an information resource only. It is not in any way intended to be nor should you rely on it as a substitute for professional medical evaluation, diagnosis, advice and treatment.This episode was sponsored by Novo Nordisk. It was created independently by My Weight - What to Know with no influence from Novo Nordisk.

Join endocrine expert Dr. David Lieb as he moderates a discussion with Dr. Karl Nadolsky, Chair of the AACE Obesity Algorithm, and Dr. Timothy Garvey, Vice Chair, as they review the 2025 AACE Algorithm for the Evaluation and Treatment of Adults with Obesity/Adiposity-Based Chronic Disease and highlight key updates since 2016. The experts discuss advances in pharmacotherapy, the evolution of complication-centric and person-centered care, and strategies to reduce weight bias in clinical practice. They also share guidance on individualizing therapy and look ahead to the future of obesity medications as new treatments emerge.

Stock market update for November 5, 2025.Follow us on Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@therundowndaily⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠This video is for informational purposes only and reflects the views of the host and guest, not Public Holdings or its subsidiaries. Mentions of assets are not recommendations. Investing involves risk, including loss. Past performance does not guarantee future results. For full disclosures, visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Public.com/disclosures⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Tom Elliott pointed out a confusing statistic.See omnystudio.com/listener for privacy information.

Bonus Episode for Nov. 4. The weight-loss-drug arms race is only heating up, as Novo Nordisk attempts to snatch drugmaker Metsera away from Pfizer. But can either company compete with Zepbound seller Eli Lilly? WSJ reporter Peter Loftus discusses what earnings from Big Pharma, including AbbVie, Bristol Myers Squibb and Merck, say about the future of the industry and how companies are responding to President Trump's drug-pricing plans, including TrumpRx. WSJ Heard on the Street columnist David Wainer hosts this special bonus episode of What's News in Earnings, where we dig into companies' earnings reports and analyst calls to find out what's going on under the hood of the American economy. Sign up for the WSJ's free Markets A.M. newsletter. Further Reading: Novo Nordisk Sweetens Offer for Metsera - WSJ Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal Why Pfizer Can Still Prevail in the Obesity Fight With Novo Nordisk The Day Pharma's Weight-Loss Gold Rush Intensified Pfizer Profit Falls Amid Lower Covid-19 Drug Demand Novo Nordisk Seeks to Outmuscle Pfizer With $9 Billion Bid for Metsera Novo Nordisk to Shake Up Board After Obesity-Market Challenges Mounjaro Powers Eli Lilly to Bumper Quarter of Earnings AbbVie Lifts Profit Outlook as Sales Rise Bristol Myers Squibb Profit Soars, Raises Revenue Guidance Merck Profit Rises on Strong Keytruda Demand GSK Lifts Guidance After Specialty Medicines Boost Sales Novartis Expects to Ride Out Patent Losses With Sales, Profit Growth Ahead Biogen Cuts Full-Year Earnings Guidance, Despite Third-Quarter Profit Rise J&J Lifts Full-Year Sales Outlook, Fueled by Pharma, Med-Device Gains Learn more about your ad choices. Visit megaphone.fm/adchoices

* Add FAAN to Anita's creds after Oct. 18.Guests: Anita Rich, DNP, RN, CHFN, CDCES, FAAN, and Jane DeMeis.Related resources:PCNA CKM tools and resources: https://pcna.net/resources/patient-education/patient-information/cardiovascular-kidney-metabolic-syndrome-resources/ 2025 ACC Expert Consensus Statement on Medical Weight Mgmt for Optimization of CV Health: https://www.jacc.org/doi/10.1016/j.jacc.2025.05.024 Adiponectin, Leptin and CV Disorders: (https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.120.314458Racial and Ethnic Disparities in Adult Obesity in the US: https://www.cdc.gov/pcd/issues/2019/18_0579.htmCardiometabolic Syndrome: A Global Health Issue: https://www.uspharmacist.com/article/cardiometabolic-syndrome-a-global-health-issueTaking Aim At Belly Fat: https://www.health.harvard.edu/newsletter_article/taking-aim-at-belly-fatGender Disparities in People Living with Obesity: https://pubmed.ncbi.nlm.nih.gov/34526743/ Systematic review and meta-analysis suggests obesity predicts onset of CKD: https://www.sciencedirect.com/science/article/pii/S0085253816307529AHA Weight-Loss Strategies for Prevention and Treatment of Hypertension: https://pubmed.ncbi.nlm.nih.gov/34538096/ Renal Fat Accumulation Assessed by MRI or CT and Metabolic Disorders: https://pmc.ncbi.nlm.nih.gov/articles/PMC12194363/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Tonya Loken from Lagom Wellness Clinic explains GLP's, how they work & why this might be the reason: See omnystudio.com/listener for privacy information.

Send us a textTemple Stewart is a returning guest on our show! Be sure to check out her first appearance on episode 528 of Boundless Body Radio!Temple Stewart is a Registered Dietitian, Certified Personal Trainer, and Health Behavior Change Specialist. Temple played D1 soccer at the University of Tennessee-Martin, where she earned her degree in Dietetics. Her internship was completed at the VA Medical Center in Bay Pines, FL.The decision to become an RDN stemmed from Temple's lifelong involvement in sports and her fascination with how proper fueling of the body affects performance. However, during her college years, she developed an unhealthy relationship with food, using food rules and diets as punishment or for comfort. This experience led her to delve into learning about food and its impact on the body, ultimately leading her to choose a career as a Registered Dietitian.Her interest in nutrition deepened after being diagnosed with Hashimoto's Thyroiditis and PCOS, further emphasizing the importance of treating the body with proper nutrition. Temple enjoys outdoor activities, and resides in the greater Phoenix, AZ area with her husband and their two kiddos!Find Temple at-https://www.templetheketonutritionist.com/IG- @the.ketogenic.nutritionistFB- @templestewartrdnYT- @The.Ketogenic.NutritionistPodcast- The Ketogenic Nutritionist with Temple Stewart, Registered DieticianFind Boundless Body at- myboundlessbody.com Book a session with us here!

Daylight Savings Time changeover health myths busted; A doctor breaks her ankle and is billed $64,000 in uncovered expenses; Vitamin D shields life-prolonging telomeres, may help depression; The vaunted DASH Diet for hypertension faces off against low-carb alternative; The critical first 1000 days after conception—early life sugar avoidance yields major later life health dividends; Do you really need hot water to disinfect your hands?

Resources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________Get the latest buzz on GLP-1 therapies and the future of metabolic medicine! This episode provides an in-depth look at what's coming out of Obesity Week in Atlanta, GA, featuring expert insights from Dave Knapp from On the Pen.Key Topics & Breakthroughs:Corporate Battle for Biotech: We break down the surprise counteroffer by Novo Nordisk to acquire Metsera, the obesity biotech company that Pfizer had recently announced it was buying, setting the stage for a major pharmaceutical turf war.Pipeline Watch: Dive into the plethora of new therapies in current clinical trials, including the latest developments from Viking Therapeutics and the push for Oral GLP-1s.GLP-1's New Frontier: Discover the groundbreaking research on GLP-1's potential role in treating alcohol and narcotics addictions. We also discuss Brenipatide and its surprising dual focus on alcohol abuse and asthma.Tune in for a comprehensive review of the medications, mergers, and clinical trials shaping the next generation of weight loss and metabolic treatments.______________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF______________________________________________________________________Join this channel to get access to perks:   / @theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1StoriesSend us Fan Mail! GetClaimable.com/PlusSideZ to appeal your GLP-1 Insurance Denails and use code PlusSideZ to save! Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==

A new report shows how doctors have noticed a change in demographic characteristics in women who attended the Coombe maternity hospital between 2018 and last year. Pat discusses these findings with Donal O'Shea, Clinical Lead for Obesity at the HSE.

Dr. Wallach discusses the root causes of critical health issues pulling from years of research. Our world is broken, built on layer after of layer of distortion and lies. Modern medicine is one of the worst in promoting lies, leading people to trust in doctors and institutions whose track record is one of failure. Dr. Wallach uses many examples to expose the brokenness we accept as normal, ultimately pointing to the root cause of so many health issues: lack of mineralization in the body.  #BardsFM_HealthAndWellness #MineralizationOfTheBody #BodyTemplePerfectDesign Bards Nation Health Store: www.bardsnationhealth.com BardsFM CAP, Celebrating 50 Million Downloads: https://ambitiousfaith.net Morning Intro Music Provided by Brian Kahanek: www.briankahanek.com MYPillow promo code: BARDS Go to https://www.mypillow.com/bards and use the promo code BARDS or... Call 1-800-975-2939.  White Oak Pastures Grassfed Meats, Get $20 off any order $150 or more. Promo Code BARDS: www.whiteoakpastures.com/BARDS Windblown Media 20% Discount with promo code BARDS: windblownmedia.com Founders Bible 20% discount code: BARDS >>> TheFoundersBible.com Mission Darkness Faraday Bags and RF Shielding. Promo code BARDS: Click here EMPShield protect your vehicles and home. Promo code BARDS: Click here EMF Solutions to keep your home safe: https://www.emfsol.com/?aff=bards Treadlite Broadforks...best garden tool EVER. Promo code BARDS: TreadliteBroadforks.com No Knot Today Natural Skin Products: NoKnotToday.com Health, Nutrition and Detox Consulting: HealthIsLocal.com Destination Real Food Book on Amazon: click here Images In Bloom Soaps and Things: ImagesInBloom.com Angeline Design: AngelineDesign.com DONATE: Click here Mailing Address: Xpedition Cafe, LLC Attn. Scott Kesterson 591 E Central Ave, #740 Sutherlin, OR  97479

In this special remote episode of the LIFTS Podcast, hosts Matthew Januszek and Mohammed Iqbal sit down with Liz Clark and Anton Severin of the Health & Fitness Association (formerly IHRSA) to unpack the 2024–2025 Global Fitness Report and explore the intersection of data, health, and the future of fitness. Recorded across three continents, this conversation dives deep into how exercise is redefining healthcare, the evolving role of recovery and wellness, and what's next for the global industry. Key topics discussed: The new definition of obesity and its massive implications for public health. How fitness must be recognized as preventative healthcare. Global fitness market growth and emerging trends. Why recovery and wellness are now the new anchors in gyms. The rise of wearables, AI, and the need for standardized fitness data. Bridging fitness with healthcare through credible evidence and policy. The future of the FIT Act and global legislative momentum. Recruiting and retaining qualified trainers and instructors. Generational shifts: from aesthetics to mental health and longevity. The evolving role of the Health & Fitness Association in shaping the industry.  

Send us a textHow mitochondria travel between cells and how this hidden communication shapes metabolism, immunity, and even potential therapies.Episode Summary: Dr. Jon Brestoff talks about mitochondrial dynamics inside cells, their transfer between unrelated cells (distinct from inheritance during division), and its roles in adipose tissue communication, macrophage cleanup, and systemic metabolic signaling; they explore how high-fat diets disrupt this process, potential hormetic benefits, therapeutic mitochondria transplantation for diseases like Leigh syndrome and obesity, and broader immunometabolism crosstalk.About the guest: Jon Brestoff, MD, PhD is an associate professor of pathology and immunology at Washington University School of Medicine in St. Louis, where he directs the Initiative for Immunometabolism.Discussion Points:Mitochondria per cell range from ~100-5000; they move via fusion/fission, vertical inheritance (cell division), or horizontal transfer without division.Transfer mechanisms: free release, extracellular vesicles, or tunneling nanotubes using cytoskeleton transport.In healthy fat tissue, adipocytes routinely donate mitochondria to macrophages for degradation (quality control); high-fat (lard-based, long-chain FA) diets block macrophage uptake, diverting mitochondria to other organs.Diverted mitochondria may induce “mito-hormesis” (mild oxidative stress boosting antioxidants) or signal adipocyte metabolic status inter-organ.Mitochondria transplantation shows promise in animal models for ischemia-reperfusion, obesity, and mitochondrial diseases.Immune cells prefer glycolysis but have low mitochondrial biomass; transplanted mitochondria tilt T-cells toward anti-inflammatory regulatory phenotype.Circulating cell-free mitochondria rival immune cell numbers.Obesity inflammation stems from dying oversized adipocytes releasing lipids/mitochondria, forming crown-like structures with pro-inflammatory macrophages.Leigh syndrome from genetic mutations disrupting the electron transport chain.Transfer may be an evolutionary relic of endosymbiosis; cells may selectively use exogenous mitochondria like a “generator” during metabolic crisis.Reference Paper:Study: The power and potential of mitochondria transferRelated Episode:M&M 260: Energy Resistance Principle in Life, Healing & Disease | Martin Picard & Nirosha MuruganSupport the showAffiliates: Seed Oil Scout: Find restaurants with seed oil-free options, scan food products to see what they're hiding, with this easy-to-use mobile app. KetoCitra—Ketone body BHB + electrolytes formulated for kidney health. Use code MIND20 for 20% off any subscription (cancel anytime) Lumen device to optimize your metabolism for weight loss or athletic performance. Code MIND for 10% off SiPhox Health—Affordable at-home blood testing. Key health markers, visualized & explained. Code TRIKOMES for a 20% discount. For all the ways you can support my efforts

In this episode of the RCP Medicine podcast, we delve into the complexities of obesity and the importance of person-centred care. Hosted by Dr Vasiliki Thanopoulou, a rheumatology and general internal medicine specialist registrar and RCP Clinical Education Fellow, she is joined by Dr Charles Fox and Dr Anne Kilverts, both retired consultant diabetes physicians with over 30 years of experience in teaching healthcare professionals how to deliver empowering, person-centred care.Together, they explore how stigma, unconscious bias, and assumptions can hinder effective communication and care for people living with obesity. Drawing on NICE guidelines and their own clinical experiences, Anne and Charles offer practical strategies for fostering empathy, respect, and shared decision-making in clinical encounters. This episode complements the RCP's e-learning modules on obesity and is part of the broader initiative to address health inequalities.Whether you're a clinician, educator, or learner, this conversation will challenge you to rethink how you approach weight-related discussions and empower patients to take control of their health journey.ResourcesRCP elearning - ObesityNICE guidelines: Overweight and obesity management | Guidance | NICELancet: Definition and diagnostic criteria of clinical obesity - The Lancet Diabetes & EndocrinologyThe European Association for the Study of Obesity: A new framework for the diagnosis, staging and management of obesity in adults - EASODr Charles Fox and Dr Anne Kilverts: www.diabetescounselling.co.ukRCP Links Education Events Membership Improving care Policy and campaigns RCP Social Media Instagram LinkedIn Facebook X Bluesky Music: Episode 50 onward - Bensound.com Episodes 1 - 49 'Impressive Deals' - Nicolai Heidlas

EP.236: Check Out LVLUP: Head to https://lvluphealth.com/DRTYNA and use code DRTYNA at checkout to get 15% off your order sitewide.  Kyal Van Der Leest from LVLUP is back on the show! He's a total mad genius when it comes to peptides, metabolism, and optimizing the systems that keep you strong and healthy. You all loved our last conversation, and this one takes things even deeper. We're talking all things GLP-1s and how to actually support your body while using them. There's a lot more to it than just weight loss. We cover gut health, liver and biliary function, hormones, thyroid, muscle preservation, and longevity pathways. We also touch on how to avoid muscle loss, how to cycle peptides properly, and why supporting your mitochondria and detox systems is key when you're microdosing or using GLP-1s for any goal. Topics Discussed: → What are the best ways to support your body while using GLP-1s? → How do peptides improve gut and liver health? → Can GLP-1s cause muscle loss, and how can you prevent it? → What supplements help balance hormones during weight loss? → How do you safely cycle peptides for longevity and performance? Sponsored By: → Puori | Go to https://puori.com/drtyna and use code DRTYNA to get 20% off → Timeline | Head to https://timeline.com/DRTYNA and get 20% off with code DRTYNA → Cozy Earth | Black Friday has come early at https://CozyEarth.com! Right now, you can stack my code DRTYNA on top of their sitewide sale, giving you up to 40% off in savings. These deals won't last, so start your holiday shopping today!  → VivaRays | Go to https://VivaRays.com and use code DRTYNA for a special discount. On This Episode We Cover:  → 00:00:00 - Introduction → 00:03:36 - Microdosing GLP-1s → 00:05:43 - GLP-1 side effects → 00:08:17 - Leaky gut & IBS → 00:17:26 - SIBO & histamine → 00:24:32 - Iron & thyroid → 00:32:39 - TUDCA support → 00:36:46 - Obesity & metabolism → 00:38:35 - Gut health & pain → 00:41:18 - Dr. Tyna's picks → 00:44:48 - Muscle loss → 00:46:08 - The science of weight loss → 00:53:04 - Longevity tools → 00:56:57 - Body recomposition → 00:58:46 - Cycling peptides → 01:05:16 - PEA benefits Dr Tyna's LVLUP Favorites:  Use code DRTYNA at checkout to get 15% off your order sitewide.  → TUDCA → ULTIMATE GI REPAIR → BPC-157 → TOTAL RECOMP → PEA → LONGEVITY  → Grab Dr. Tyna's FREE GLP1 Intro Course: https://www.drtyna.com/ozempicuncovered Further Listening:  → EP. 200 | Peptides 101: Unlock Optimized Gut, Brain and Recovery | Kyal Van Der Leest of LVLUP Check Out LVLUP: → Head to https://lvluphealth.com/DRTYNA and use code DRTYNA at checkout to get 15% off your order sitewide.  Disclaimer: Information provided in this podcast is for informational purposes only. This information is NOT intended as a substitute for the advice provided by your physician or other healthcare professional, or any information contained on or in any product. Do not use the information provided in this podcast for diagnosing or treating a health problem or disease, or prescribing medication or other treatment. Always speak with your physician or other healthcare professional before taking any medication or nutritional, herbal or other supplement, or using any treatment for a health problem. Information provided in this blog/podcast and the use of any products or services related to this podcast by you does not create a doctor-patient relationship between you and Dr. Tyna Moore. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent ANY disease.

The Bible encourages us to take our health seriously, and obesity is an issue that affects many Americans. Learn how you can take steps to overcome this disorder and improve your physical and spiritual health. Join John Bradshaw and Dr. David DeRose as they discuss practical, Bible-based health principles you can implement today.

The Bible encourages us to take our health seriously, and obesity is an issue that affects many Americans. Learn how you can take steps to overcome this disorder and improve your physical and spiritual health. Join John Bradshaw and Dr. David DeRose as they discuss practical, Bible-based health principles you can implement today.

Joseph Haas, senior writer, Scrip, speaks to guest panelists Robert Darwin, partner, Sidley law firm, and Arda Ural, Americas Life Sciences Leader, EY.

John writes in wondering whether the 10,000 steps rule applies eqully to everyone, given the range of body types and fitness among the population. James Tytko wondered where the 10,000 number came from in the first place, and sought an answer to John's question with the help of Dr Raj Amarnani, Consultant in Sport, Exercise and Muscoskeletel Medicine... Like this podcast? Please help us by supporting the Naked Scientists

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today's focus is on a series of significant advancements that are poised to reshape the landscape of drug development, regulatory standards, and patient care.Eli Lilly has made remarkable strides with its dual-action obesity medications, Zepbound and Mounjaro. Despite being removed from the CVS formulary, these drugs have achieved exceptional sales figures, reaching $10 billion in a single quarter. This success can be attributed to Lilly's innovative direct-to-consumer sales strategy, which exemplifies how modern marketing approaches can overcome traditional market barriers. Additionally, Eli Lilly's partnership with Walmart to expand access to Zepbound through retail pharmacy pickups exemplifies a strategic approach to enhancing patient access to crucial medications. By leveraging Walmart's extensive retail network, this collaboration facilitates easier access to obesity treatments—a significant public health challenge—enhancing both patient convenience and broadening market reach for Lilly's products. These achievements not only highlight the potential of strategic marketing but also underscore a growing demand for effective obesity treatments within the pharmaceutical industry.In another exciting development, Alnylam Pharmaceuticals has reported impressive sales figures for Amvuttra, a treatment for transthyretin amyloid cardiomyopathy. Surpassing analysts' expectations, this success signals a growing market for treatments targeting rare diseases and emphasizes the importance of strategic market expansion to reach underserved patient populations.Meanwhile, Bristol Myers Squibb's anticipated schizophrenia treatment, Cobenfy, has experienced a lukewarm market entry. While meeting initial expectations in its first year, it has yet to create the breakthrough impact investors anticipated. This situation highlights the challenges even well-hyped pharmaceuticals face upon launch and underscores the need for continuous strategic planning to ensure market penetration and sustained growth.A surprising development in mergers and acquisitions comes from Novo Nordisk's $6.5 billion counteroffer to acquire Metsera, an obesity biotech initially targeted by Pfizer. This aggressive move reflects intense competition in the obesity drug market and illustrates the high stakes involved in acquiring promising biotech assets that could potentially transform treatment paradigms for chronic conditions like obesity.The vaccine industry is navigating its own set of challenges with declining sales across the board. However, Merck's adult pneumococcal vaccine Capvaxive has shown promising initial sales figures. As the first pneumococcal vaccine specifically designed for adults, Capvaxive indicates a potential niche market that Merck could successfully capture.On the regulatory front, significant measures are being taken by the FDA to boost biosimilar availability against drug pricing pressures. New draft guidance aims to eliminate clinical testing requirements for biosimilars and categorize all approved biosimilars as "interchangeable." This initiative could significantly reduce biologic medicine costs post-patent expiration and increase competition in the market, potentially making essential medications more accessible to patients. Additionally, the FDA is proposing streamlined biosimilar approval pathways aimed at reducing overall bio-drug costs—a welcome move reflecting concerted efforts to make essential medications more affordable and accessible globally.Argenx has reported positive trial results for Vyvgart in treating generalized myasthenia gravis (gMG), highlighting its commitment to addressing unmet needs within this patient population. These findings could expand treatment options for gMG patients who have been previously overlooked in thSupport the show

In this episode, Dr. Brendan McCarthy, Chief Medical Officer of Protea Medical Center, dives deep into estrone, one of the three key estrogens, and explains why understanding it is crucial for women's health. Learn about: The differences between estradiol, estriol, and estrone How estrone levels shift during perimenopause and menopause Why oral estrogen can dramatically increase estrone The impact of lifestyle factors like diet, body fat, stress, alcohol, and sedentary behavior on estrogen balance Practical tips to support healthy estrogen metabolism naturally Dr. McCarthy breaks down complex biochemistry in a clear, actionable way so you can take charge of your hormonal health.   Citations: 1. Bulun, Serdar E., et al. “Aromatase and Estrogen Biosynthesis in Adipose Tissue.” Endocrine Reviews, vol. 23, no. 3, 2002, pp. 305–342. 2. Labrie, Fernand, et al. “Importance of the Intracrinology of Estrogen Synthesis in Peripheral Tissues in Postmenopausal Women.” Journal of Steroid Biochemistry and Molecular Biology, vol. 118, nos. 4–5, 2010, pp. 273–279. 3. Sasano, Hironobu, and Toshihiko Harada. “Differential Expression of Aromatase and 17β-Hydroxysteroid Dehydrogenase Isoenzymes in Human Tissues.” Journal of Steroid Biochemistry and Molecular Biology, vol. 86, no. 3–5, 2003, pp. 327–333. 4. Yager, James D., and Nancy E. Davidson. “Estrogen Carcinogenesis in Breast Cancer.” New England Journal of Medicine, vol. 354, no. 3, 2006, pp. 270–282. 5. Cavalieri, Ercole L., and Eleanor G. Rogan. “Depurinating Estrogen-DNA Adducts, Mechanisms of Formation, and Prevention.” Clinical Cancer Research, vol. 16, no. 3, 2010, pp. 596–602. 6. Suba, Zsuzsanna. “Circulating Estrogens and Estrogen Metabolism in Obese Women.” Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 11, 2013, pp. 4336–4344. 7. Simpson, Evan R., and Konstanze C. Pike. “Aromatase Expression in Adipose Tissue: Relationship to Obesity and Insulin Resistance.” Endocrinology, vol. 156, no. 9, 2015, pp. 3422–3435. 8. Key, Timothy J., et al. “Circulating Sex Hormones and Breast Cancer Risk Factors in Postmenopausal Women: Reanalysis of 13 Studies.” British Journal of Cancer, vol. 105, no. 5, 2011, pp. 709–722. 9. Stanczyk, Frank Z., et al. “Oral, Transdermal and Injectable Hormone Therapy: Pharmacokinetics and Effects on Estrone/Estradiol Ratios.” Menopause, vol. 24, no. 9, 2017, pp. 1080–1090. 10. Santen, Richard J., et al. “Estrogen Bioidentical Hormone Therapy: Route of Administration and Risk.” Journal of Clinical Endocrinology and Metabolism, vol. 105, no. 7, 2020, pp. 2062–2074. 11. Zeleniuch-Jacquotte, Anne, et al. “Postmenopausal Levels of Estrone, Estradiol, and Estrone Sulfate and Breast Cancer Risk.” Cancer Epidemiology, Biomarkers & Prevention, vol. 23, no. 8, 2014, pp. 1531–1539. 12. Dall, Gabriella V., and Christine L. Clarke. “Local Estrogen Biosynthesis and Signaling in Breast Cancer Progression.” Steroids, vol. 78, no. 7, 2013, pp. 639–646. 13. Heald, Anthony H., et al. “Relationships Between Serum Estrone, Insulin Resistance, and Adiposity in Postmenopausal Women.” Clinical Endocrinology, vol. 67, no. 3, 2007, pp. 340–345. 14. Kuiper, George G. J. M., et al. “Estrogen Receptor β Selectivity of Estriol and Implications for Tissue-Specific Effects.” PNAS, vol. 94, no. 17, 1997, pp. 9105–9110. 15. Michnovicz, Joseph J., et al. “Dietary Indoles and Estrogen Metabolism: Effects of Cruciferous Vegetable Intake.” Journal of Nutrition, vol. 134, no. 12, 2004, pp. 3479S–   Dr. Brendan McCarthy is the founder and Chief Medical Officer of Protea Medical Center in Arizona. With over two decades of experience, he's helped thousands of patients navigate hormonal imbalances using bioidentical HRT, nutrition, and root-cause medicine. He's also taught and mentored other physicians on integrative approaches to hormone therapy, weight loss, fertility, and more. If you're ready to take your health seriously, this podcast is a great place to start.  

For the first time in a while, obesity numbers are dropping in the U.S.  Some believe it is due to the use of popular GLP-1s such as Mounjaro and Ozempic, but while those drugs may be making people thinner, diabetes rates are on the rise. So what gives? Greg and Holly discuss.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/GPQ865. CME credit will be available until November 3, 2026.Making Connections to Improve Patient Care in Obesity, Metabolism, and Liver Health In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Obesity Medicine Association. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/GPQ865. CME credit will be available until November 3, 2026.Making Connections to Improve Patient Care in Obesity, Metabolism, and Liver Health In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Obesity Medicine Association. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/GPQ865. CME credit will be available until November 3, 2026.Making Connections to Improve Patient Care in Obesity, Metabolism, and Liver Health In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Obesity Medicine Association. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/GPQ865. CME credit will be available until November 3, 2026.Making Connections to Improve Patient Care in Obesity, Metabolism, and Liver Health In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Obesity Medicine Association. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

  Headlines: – Welcome to Mo News (02:00) – Hurricane Melissa Makes Historic Landfall in Jamaica As Category 5 Storm (05:40) – US Kills 14 In Strikes On Alleged Drug Boats in Pacific, In Deadliest Maritime Attacks Yet (09:00) – Netanyahu Orders ‘Forceful' Strikes on Gaza After Hamas Breaks Ceasefire (15:20) – Mass Civilian Killings Reported In Sudanese City Seized By Paramilitary Group (19:00) – Texas Sues Tylenol Makers, Claiming They Hid Autism Risks (22:30) – U.S. Obesity Rates Fall As Record Number Of Americans Take GLP-1 Injectables (25:20) – Francis Ford Coppola Forced To Sell Prized Watches After His Movie Bombs (27:10) – On This Day In History (28:20) Thanks To Our Sponsors:  – ⁠LMNT⁠ - Free Sample Pack with any LMNT drink mix purchase –⁠ Industrious⁠ - Coworking office. 50% off day pass | Promo Code: MONEWS50 – Incogni - 60% off an annual plan| Promo Code: MONEWS – Factor Meals – 50% your first box plus free shipping | Promo Code: monews50off – Monarch Money - 50% off your first year | Promo Code: MONEWS – BetterHelp – 10% off your first month 

In this episode, we take a closer look at tirzepatide, a type 2 diabetes medication also used to help with weight loss. Postmenopause weight gain can be a normal part of aging, and there are some questions about whether medications like tirzepatide could be useful and safe for postmenopausal women. Host Aaron Lohr talks with Maria Daniela Hurtado Andrade, MD, PhD, assistant professor of medicine at Mayo Clinic Florida, and Regina Castaneda, MD, a research fellow at Mayo Clinic College of Medicine & Science. They presented an abstract at ENDO 2025 titled, “One-Year Real-World Weight Loss Outcomes with Tirzepatide in Postmenopausal Women With and Without Hormone Therapy.” Show notes are available at https://www.endocrine.org/podcast/enp105 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Research is more than just finding interesting stats. It's about finding better ways to deliver savings, simplicity, and support. In this episode, you'll hear from managed care pharmacy researchers who are doing just that, delivering data driven insights to drive affordability and access in health care.  Pat Gleason, PharmD, BCPS, FCCP, FAMCP, assistant vice president of health outcomes; Nick Friedlander, PharmD, clinical program pharmacist; and Simone Ndujiuba, PharmD, BCOP, clinical oncology pharmacist senior principal; and host Alex Cook, senior public relations manager, discuss how Prime's research helps address affordability and accessibility issues and guides health care providers and peers toward clarity on treatment for complex health conditions. Research topics covered:Three-Year Real-World Adherence and Persistence to Glucagon-Like Peptide-1 Receptor Agonists Among Commercially Insured Adults with Obesity without Diabetes Trends in Real-World Persistence to Weight Loss Glucagon-Like Peptide-1 Receptor Agonists from 2021 to 2024 Among Commercially Insured Adults without Diabetes — This study earned a platinum award from AMCP.  Impact of a Medical Claims Automated Glucagon Like Peptide-1 Drugs Prior Authorization Program— This study earned a gold award from AMCP.Validation of Long-term Savings from a Pharmacist-to-Prescriber Telephonic Intervention — This study earned a gold award from AMCP. Total Cost of Care and Adverse Effects Assessment of Bispecific T-cell Engagers and Chimeric Antigen Receptor T-cell Therapies for Relapsed Refractory Follicular Lymphoma  -------------------------Content in this podcast is for informational or educational purposes only.The content also does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.

Pre-Order The Forever Strong PLAYBOOK and receive exclusive bonuses: https://drgabriellelyon.com/playbook/Want ad-free episodes, exclusives and access to community Q&As? Subscribe to Forever Strong Insider: https://foreverstrong.supercast.comIn this episode, Dr. Gabrielle Lyon sits down with Dr. Heidi van den Brink; one of the only scientists in the world studying the ovarian transition from fertility to menopause. Together, they unpack what textbooks and wellness influencers often miss: the biology behind how your ovaries, uterus, metabolism, and nutrition interact across every stage of a woman's life. Dr. Heidi reveals the never-before-seen dynamics of the ovarian cycle, how follicles develop in “waves,” and what really happens during the menopause transition. They discuss how undernutrition, obesity, and metabolic health shape reproductive hormones; why early menarche and delayed ovulation matter for long-term health; and the surprising connection between your gut microbiome, bile acids, and fertility. If you've ever been told to “balance your hormones” with seed cycling, apps, or supplements, this episode separates myths from mechanisms. It's a masterclass in understanding the science of your hormones and how to truly support reproductive health through every decade of life.Chapter Markers0:00 - Can You Get Pregnant While on Your Period? 1:21 - Intro to Dr. Heidi & Ovarian Cycle Research 3:39 - The Uterine Cycle vs. The Ovarian Cycle 6:19 - Follicle Waves: The Hidden Drama in Your Ovaries 10:38 - Novel Discovery: Follicle Waves in the Luteal Phase 12:00 - Why One Follicle is Selected for Ovulation 13:17 - Does Nutrition Affect Ovarian Function? 14:48 - The Variation in Menstrual Cycles (It's Not Always 28 Days) 17:23 - The Impact of Obesity on the Ovarian Cycle 18:11 - The Problem of Luteal Phase Defects & Fertility 24:52 - Ovarian Morphology as a Bio-Marker of Health 26:54 - How Undernutrition Affects Ovarian Health 31:56 - The Metabolic Tipping Point of PCOS (Polycystic Ovary Syndrome) 33:26 - The Myth of the "String of Pearls" Ovary 35:25 - The Menopause Transition & Rogue Follicles 39:04 - Can We Predict Menopause by Scanning Ovaries? 45:59 - Early Menarche (First Period) and Long-Term Disease Risk 48:33 - The Surprising Link Between Puberty Timing and Environment 52:28 - The Role of Leptin in Reproductive Health 55:50 - Debunking the Myth: Can Nutrition Cure PCOS? 59:07 - PCOS Diet Myths (Fruit, Timing, and Supplements) 1:04:40 - Fish Oil for Menstrual Cramps (Dysmenorrhea) 1:08:37 - Breakthrough: Bile Acid, The Gut Microbiome, and Ovulation 1:11:50 - Closing RemarksWho is Heidi Vanden Brink:Dr. Vanden Brink is a reproductive physiologist with over a decade of research in nutrition, metabolism, and female reproductive health. Her work focuses on how diet and metabolic conditions like obesity influence reproductive development during adolescence, with the goal of preventing disorders such as PCOS.Find Heidi Vanden Brink at: Texas A&M University: https://nutrition.tamu.edu/people/vanden-brink-heidi/ Google Scholar:

GLP-1 receptor agonists have emerged as a groundbreaking tool in obesity treatment. In this episode, Dr. Spencer Nadolsky (an obesity specialist) explains how these medications are now yielding unprecedented weight loss outcomes in people with obesity.  The discussion centers on GLP-1 agonist drugs like semaglutide and tirzepatide: how they work, how much weight loss they can produce, and why they represent a paradigm shift in obesity management.  Importantly, the conversation addresses practical aspects of using these drugs, including managing their side effects and optimizing patients' diet and lifestyle while on therapy. This topic is of great significance to nutrition science, clinical practice, and public health. Obesity is a chronic, relapsing condition that has proven difficult to treat with lifestyle changes alone. The advent of GLP-1 agonists offers new hope by inducing weight loss levels previously seen only with surgical interventions.  Understanding these medications is crucial for healthcare professionals: it enables evidence-based prescribing, proper patient counseling on diet and side effects, and integration of medication with lifestyle interventions.  Discussing safety and long-term use is vital, as millions more patients might use these drugs in coming years. From a public health perspective, GLP-1 agonists prompt debates about access and cost, given their high price and life-changing potential. Timestamps [03:25] Conversation with Dr. Spencer Nadolsky begins [05:24] Mechanism and types of GLP-1 medications [07:55] Efficacy and weight loss results [16:53] Common side effects and management [22:57] Muscle loss concerns and clinical insights [28:09] Addressing nutritional concerns with GLP-1 medications [29:38] Exploring potential benefits beyond weight loss [33:48] Marketing and misconceptions around GLP-1 [36:59] Public health and accessibility issues [43:25] Future research [46:16] Key ideas segment (Premium-only) Related Resources Go to episode page Join the Sigma email newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course Vineyard – Dr. Nadolsky's Virtual Clinic (US) Instagram: @drnadolsky @sigmanutrition Related episodes: 460: Dr. Priya Sumithran – Body Fat Regulation, Pros & Cons of Weight Loss Interventions, and GLP-1 Receptor Agonists 324: Fatima Cody Stanford, MD – Obesity Treatment & Weight Bias 395: Prof. Carel Le Roux – Current Thinking in Obesity Treatment

From the skyrocketing costs of drugs like Ozempic and Wegovy to the moral and economic debate over obesity as a disease, Michael explores both sides of this billion-dollar question: "Should Congress mandate Medicaid to cover weight-loss medications like GLP-1s?" Listen to his take, then vote on today's poll at smerconish.com. He also revisits yesterday's poll question on the political buzz around Kamala Harris, Gavin Newsom, and the 2028 race — plus some media mayhem from New York's mayoral contest. Please rate, review, and share this podcast. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

You've heard it all: “The truth about carbs,” “The truth about hormones,” “The truth about fasting.” But here's the real truth—context matters, and no single “truth” out there applies to every woman, every body, or every season of life.In this episode, I break down why most health advice is only a sliver of the full picture—and why lasting change doesn't come from copying and pasting what worked for someone else. Instead, you'll learn how to approach your health like a scientist: with curiosity, patience, and small, consistent actions that actually get down into your cells. You're not broken. You're just stuck in the wrong story.Here's what we cover:Why most “truths” about health are missing contextThe real reason your results aren't changingHow long it actually takes to see change at the cellular levelThe drip-drip-drip method vs. the bucket approach to health5 evidence-based habits to start today: walk, track, sleep, plan, eat proteinWhat your biology needs (and what it doesn't)There's no magic protocol. Just consistent inputs over time. Start anywhere. Because anywhere is better than “someday.”Get Weekly Health Tips:  thrivehealthcoachllc.comLet's Connect:@‌ashleythrivehealthcoach or via email: ashley@thrivehealthcoachingllc.comPodcast Produced by Virtually You!Sources: • Barrès, R., Yan, J., Egan, B., Treebak, J. T., Rasmussen, M., Fritz, T., & Zierath, J. R. (2012). Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab, 15(3), 405–411. https://doi.org/10.1016/j.cmet.2012.01.001 • Baumeister, R. F., & Tierney, J. (2011). Willpower: Rediscovering the greatest human strength. Penguin. • Berg, J. M., Tymoczko, J. L., & Gatto, G. J. (2019). Biochemistry (9th ed.). W. H. Freeman. • Cohen, A. A., Milot, E., Yong, J., Seplaki, C. L., Fülöp, T., & Fried, L. P. (2016). Multi-system physiological dysregulation during aging. Mech Ageing Dev, 156, 86–94. • Guyton, A. C., & Hall, J. E. (2021). Textbook of medical physiology (14th ed.). Elsevier. • Lee, I.-M., Shiroma, E. J., Kamada, M., Bassett, D. R., Matthews, C. E., & Buring, J. E. (2020). Steps, intensity, and mortality in older women. JAMA Intern Med, 180(8), 1103–1112. • Lichtman, S. W., Pisarska, K., Berman, E. R., Pestone, M., Dowling, H., & Heymsfield, S. B. (1992). Self-reported vs actual caloric intake and exercise. N Engl J Med, 327(27), 1893–1898. • McEwen, B. S. (1998). Protective and damaging effects of stress mediators. N Engl J Med, 338(3), 171–179. • Morton, R. W., Murphy, K. T., McKellar, S. R., Schoenfeld, B. J., Helms, E., & Phillips, S. M. (2018). Protein supplementation and resistance training. Br J Sports Med, 52(6), 376–384. • Richter, E. A., & Hargreaves, M. (2013). Exercise, GLUT4, and muscle glucose uptake. Physiol Rev, 93(3), 993–1017. • Spiegel, K., Tasali, E., Penev, P., & Van Cauter, E. (2004). Sleep curtailment lowers leptin, raises ghrelin. Ann Intern Med, 141(11), 846–850. • Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2007). Obesity-associated gut microbiome. Nature, 444(7122), 1027–1031. • Van Cauter, E., Holmback, U., Knutson, K., Leproult, R., Miller, A., Nedeltcheva, A., & Spiegel, K. (2008). Sleep loss and metabolic function. Horm Support the show

#68: We all know babies don't need added sugar—but avoiding it is harder than you think. In this episode, I'm joined by Dr. Robert Lustig, one of the world's leading experts on sugar and metabolism, to uncover the hidden ways sugar sneaks into baby foods and what parents can do to keep it out. If you've ever wondered how to protect your baby from added sugar and help them build a lifetime of positive food preferences, this conversation will open your eyes to what's really going on in our food supply—and what you can do about it. Listen to this episode to learn: 1. How to spot hidden sugars in common baby foods, pouches and yogurts - and then which real food alternatives you can swap in instead. 2. Why Dr. Lustig believes pureeing vegetables for your baby does not convey the same health beliefs as eating the intact versions of these foods 3. What the difference between apples, applesauce and apple juice is when it comes to fiber and carbohydrate load and impact on blood sugar levels Shownotes for this episode can be found here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.babyledweaning.co/podast/68 Links from this episode: • ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Dr. Lustig's personal / professional website is located at www.robertlustig.com • The non-profit Eat Real that Dr. Lustig is the Chief Medical Officer of is located here: https://eatreal.org/about/ • ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Dr. Lustig's UCSF Sugar Science resource (...the one that vetted 8,000 clinical research articles down into a few infographics for you :) is located here: https://sugarscience.ucsf.edu/ ⁠⁠⁠ Dr. Lustig's books on Amazon (affiliate links) • ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Fat Chance: Beating the Odds Against Sugar, Processed Food, Obesity and Disease • Metabolical: The Lure and Lies of Processed Food, Nutrition, and Modern Medicine (release May 2021) Movies that Dr. Lustig has been featured in that were mentioned in the podcast episode • Fed Up • ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Sugar Coated: How the Food Industry Seduced the World One Spoonful at a Time • ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Sugar the Bitter Truth (...Dr. Lustig in the longest viral video you'll ever watch!) Baby-Led Weaning with Katie Ferraro Links • Baby-Led Weaning with Katie Ferraro program with the 100 First Foods™ Daily Meal Plan, join here: https://babyledweaning.co/program ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Other episodes related to this topic: • Episode 269 - Agave: Is it Safe to Offer Babies Agave in Place of Added Sugar? • Episode 309 - Added Sugars: Which Ones to Avoid for BLW • Episode 328 - Managing Blood Sugar + Gestational Diabetes with Casey Seiden, RDN, CDCES⁠

While we're making progress in TREATING cancer, worldwide cancer INCIDENCE is soaring, especially among young people; New guidelines for colon cancer screening urge earlier start at age 45; Rates of peanut allergy are declining as more parents follow revised advice to introduce nuts earlier to kids; What's with all the buzz about methylene blue? Legalization and stronger pot are creating an epidemic of ER visits for uncontrolled vomiting, debilitating abdominal pain; New smart toilet gives you a report card on your poop; When Zoloft doesn't work for anxiety.

Welcome back to Dial Emma! Each week, I'll be answering your dilemmas with honesty, empathy, and a few therapeutic truth bombs to help you make sense of life's stickiest moments. If you've ever wished you had a therapist in your back pocket, Dial Emma is here to help.Our dilemma this week comes from a listener who is navigating a lifelong struggle with weight and self-acceptance. After years of dieting without lasting success, she finally found hope through weight-loss injections - but when she had to stop due to the cost, the weight, and the shame that comes with it, returned. Now, she finds herself caught between the pressure to start the medication again and the desire to accept herself as she is.To help me respond to our lovely listener and provide some much needed scientific insight, I'm delighted to be joined by Dr. Fredrik Nyström, professor of medicine at Linköping University in Sweden and author of Lighten the Load on Your Shoulders. Fredrik has spent more than 30 years working within endocrinology and studying hormone-producing glands and organs, hypertension, obesity, and diabetes.Fredrik and I explore the complexities of weight management, the societal pressures that often influence our relationship with food and appearance, and the psychological impacts of dieting. We also discuss the role of GLP-1 agonists in weight loss, the importance of self-acceptance in a world filled with conflicting messages about body image, and the power of challenging societal norms and embracing personal choices when it comes to our health and wellbeing.If you have a dilemma for Emma, please fill out this form. ---Dial Emma is hosted by Emma Reed Turrell, produced by Lauren Brook.---Social media:Emma Reed Turrell @emmareedturrellDial Emma @dialemmapodcastEmail: contact@dial-emma.uk

Seen TikTok videos about taking "just a little bit" of Ozempic or counting pen clicks instead of using the prescribed dose? That's microdosing, and it's showing up everywhere—from social media to patient discussions. In this episode, I will cut through the hype to explain what microdosing GLP-1 medications really means, why people are trying it (spoiler: cost and side effects), and what the research actually says. I will discuss the concept of "super responders" who seem to do well on lower doses, the lack of scientific backing for DIY microdosing, and the real risks of using compounded or diluted versions of these medications. Tune in to learn why working with your healthcare provider is essential for safe, effective dosing—and discover legitimate ways to manage side effects and costs without compromising your results.   Episode Highlights: What microdosing GLP-1s actually means The difference between super responders and unsafe microdosing Why professional organizations don't endorse microdosing Hidden risks of compounded and diluted medications Safe alternatives for managing side effects and medication costs   Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH.  Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014.  In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss,  where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, “Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.   Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

#68: We all know babies don't need added sugar—but avoiding it is harder than you think. In this episode, I'm joined by Dr. Robert Lustig, one of the world's leading experts on sugar and metabolism, to uncover the hidden ways sugar sneaks into baby foods and what parents can do to keep it out. If you've ever wondered how to protect your baby from added sugar and help them build a lifetime of positive food preferences, this conversation will open your eyes to what's really going on in our food supply—and what you can do about it. Listen to this episode to learn: 1. How to spot hidden sugars in common baby foods, pouches and yogurts - and then which real food alternatives you can swap in instead. 2. Why Dr. Lustig believes pureeing vegetables for your baby does not convey the same health beliefs as eating the intact versions of these foods 3. What the difference between apples, applesauce and apple juice is when it comes to fiber and carbohydrate load and impact on blood sugar levels Shownotes for this episode can be found here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.babyledweaning.co/podast/68 Links from this episode: • ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Dr. Lustig's personal / professional website is located at www.robertlustig.com • The non-profit Eat Real that Dr. Lustig is the Chief Medical Officer of is located here: https://eatreal.org/about/ • ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Dr. Lustig's UCSF Sugar Science resource (...the one that vetted 8,000 clinical research articles down into a few infographics for you :) is located here: https://sugarscience.ucsf.edu/ ⁠⁠⁠ Dr. Lustig's books on Amazon (affiliate links) • ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Fat Chance: Beating the Odds Against Sugar, Processed Food, Obesity and Disease • Metabolical: The Lure and Lies of Processed Food, Nutrition, and Modern Medicine (release May 2021) Movies that Dr. Lustig has been featured in that were mentioned in the podcast episode • Fed Up • ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Sugar Coated: How the Food Industry Seduced the World One Spoonful at a Time • ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Sugar the Bitter Truth (...Dr. Lustig in the longest viral video you'll ever watch!) Baby-Led Weaning with Katie Ferraro Links • Baby-Led Weaning with Katie Ferraro program with the 100 First Foods™ Daily Meal Plan, join here: https://babyledweaning.co/program ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Other episodes related to this topic: • Episode 269 - Agave: Is it Safe to Offer Babies Agave in Place of Added Sugar? • Episode 309 - Added Sugars: Which Ones to Avoid for BLW • Episode 328 - Managing Blood Sugar + Gestational Diabetes with Casey Seiden, RDN, CDCES⁠

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/CKQ865. CME/AAPA/IPCE credit will be available until October 23, 2026.Tackling Obesity in Psoriatic Arthritis: Key to Better Outcomes and Overall Health In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

Leyla Muedin, a registered dietitian nutritionist, discusses the gastrointestinal (GI) side effects commonly experienced by patients using GLP-1 medications such as Ozempic and Rybelsus. Leyla introduces a nutraceutical called Digexin, created by N-X-T-U-S-A, which has shown promise in mitigating these side effects and improving overall well-being. The episode highlights the need for patients to prioritize animal protein intake and incorporate strength training to maintain muscle mass, especially when taking GLP-1 medications. Leyla emphasizes the importance of developing healthy habits and lifestyle changes to sustain weight loss after discontinuing these drugs.

In the 1980s, scientists made a discovery that would eventually lead to the development of drugs now used worldwide to treat diabetes and to help people manage obesity through weight loss injections.One of the key scientists behind this breakthrough was Svetlana Mojsov. She discovered that a hormone called GLP-1 (glucagon-like peptide-1) plays an important role in how our bodies respond to food. Svetlana's work laid the foundation for a drug company to develop treatments based on GLP-1 — first for type 2 diabetes, and later for weight loss. She tells Gill Kearsley her story.Eye-witness accounts brought to life by archive. Witness History is for those fascinated by the past. We take you to the events that have shaped our world through the eyes of the people who were there. For nine minutes every day, we take you back in time and all over the world, to examine wars, coups, scientific discoveries, cultural moments and much more. Recent episodes explore everything from the death of Adolf Hitler, the first spacewalk and the making of the movie Jaws, to celebrity tortoise Lonesome George, the Kobe earthquake and the invention of superglue. We look at the lives of some of the most famous leaders, artists, scientists and personalities in history, including: Eva Peron – Argentina's Evita; President Ronald Reagan and his famous ‘tear down this wall' speech; Thomas Keneally on why he wrote Schindler's List; and Jacques Derrida, France's ‘rock star' philosopher. You can learn all about fascinating and surprising stories, such as the civil rights swimming protest; the disastrous D-Day rehearsal; and the death of one of the world's oldest languages.(Photo: Injection pens. Credit: Carsten Snejbjerg/Bloomberg via Getty Images)